An Analysis Of ResMed Inc. (RMD)’s Weekly Performance

0
20

As of Wednesday close, ResMed Inc.’s (NYSE:RMD) stock was down -$0.32, moving down -0.14 percent to $229.34. The average number of shares traded per day over the past five days has been 328,360 shares. 5 times new highs have been achieved over the past 5 days, with a $4.76 gain in that time frame. In the last twenty days, the average volume was 536,755, while in the previous 50 days, it was 497,172.

Since last month, RMD stock retreated -0.28%. Shares of the company fell to $206.67 on 11/04/22, the lowest level in the past month. A 52-week high of $268.77 was reached on 03/18/22 after having rallying from a 52-week low of $189.40. Since the beginning of this year, RMD’s stock price has dropped by -11.95% or -$31.14, and marked a new high 2 times. However, the stock has declined by -14.67% since its 52-week high.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


RMD stock investors should be aware that ResMed Inc. (RMD) stock had its last reported insider trading activity 2 days ago on Nov 22. Leong Justin, the President, Asia Latin America of the company, disposed of 3,777 shares for $229.50 on Nov 22. It resulted in a $866,820 divestment by the insider. Douglas Robert Andrew sold 11,280 shares at an average price of $222.07 on Nov 15. The insider now owns 40,186 shares following the transaction. On Nov 15, Chief Executive Officer Farrell Michael J. sold 5,675 shares at $224.64 apiece. The transaction was valued at $1,274,837.

Valuation Metrics

Right now, ResMed Inc. (RMD) has a P/E ratio of about 42.89. The stock’s beta is 0.47. Besides these, the trailing price-to-sales (P/S) ratio of 9.05, the price-to-book (PB) ratio of 9.78, and the price-to-cash flow ratio of 429.67 may also be considered.

The latest dividend of $0.44 per share was paid out, remained unchanged from last year’s $0.44. On Friday August 12 2022, a $0.02 dividend increase was announced.

Financial Health

In the three months ended September 29, ResMed Inc.’s quick ratio stood at 1.70, while its current ratio was 2.90, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.23, and the total debt-to-equity ratio was 0.23. On the profitability front, the trailing twelve-month gross margin is 56.80% percent. In the year ended September 29, operating margins totaled 28.00%. Based on annual data, RMD earned $2.02 billion in gross profit and brought in $3.58 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 19.80%. Return on equity (ROE) for the past 12 months was 23.80%.

In ResMed Inc.’s quarter-end financial report for September 29, it reported total debt of $785.44 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. RMD’s revenue fell -36.74% to $1.3 billion during the quarter, while net income inched up to $943.92 million. While analysts expected ResMed Inc. to report $1.52 quarterly earnings, the actual figure was $1.51 per share, beating the consensus estimate by -0.70%. During the quarter, the company generated $319.77 million in EBITDA. The liabilities of ResMed Inc. were 1.74 billion at the end of its most recent quarter ended September 29, and its total debt was $930.63 million. The value of shareholders’ equity is $146.48 million.

Technical Picture

This quick technical analysis looks at ResMed Inc.’s (RMD) price momentum. With a historical volatility rate of 23.32%, the RSI 9-day stood at 62.10% on 23 November.

With respect to its five-day moving average, the current ResMed Inc. price is up by +2.12% percent or $4.76. At present, RMD shares trade -1.98% below its 20-day simple moving average and +5.96% percent above its 100-day simple moving average. However, the stock is currently trading approximately -1.66% below its SMA50 and -4.86% below its SMA200.

Stochastic coefficient K was 91.33% and Stochastic coefficient D was 85.30%, while ATR was 6.22. Given the Stochastic reading of 88.97% for the 14-day period, the RSI (14) reading has been calculated as 57.89%. As of today, the MACD Oscillator reading stands at 3.66, while the 14-day reading stands at 7.08.

Analyst Ratings

ResMed Inc. downgraded its rating on ResMed Inc. (NYSE: RMD) to a Neutral in a note to investors on October 28, 2022. The analysts firm previously had a Buy rating on the stock.ResMed Inc. (RMD) has been rated Overweight by analysts. According to 0 brokerage firms, RMD is a sell, and 6 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 4 analysts rate ResMed Inc. stock as buy, with 10 recommending it as overweight.

With a median target price of $244.53, the current consensus forecast for the stock is $209.28 – $280.00. Based on these forecasts, analysts predict ResMed Inc. (RMD) will achieve an average price target of $244.99.

LEAVE A REPLY

Please enter your comment!
Please enter your name here